FIELD: medicine, cardiology.
SUBSTANCE: in addition to traditional treatment with broncholytics it is necessary to apply analapryl at increasing dosages starting from 2.5 up to 10 mg/d, therapy course lasts for 24 d. Due to anti-ischemic action of analapryl the development of bronchospasm has been excluded.
EFFECT: higher efficiency of therapy.
3 ex, 1 tbl
Authors
Dates
2005-12-20—Published
2003-09-03—Filed